,i  #aai? ,,congress  #a/ ,session  ,h4 
,r4 #ceie  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,may #bc1 #bjbe,mr4   
,k5n$y ( ,utah introduc$ ! foll[+ bill2 
:i* 0 ref]r$ to ! ,committee on ,en]gy &
 ,comm]ce  ,a ,,bill  ,to am5d ! ,public
 ,heal? ,s]vice ,act to provide = !     
disclosure ( c]ta9 records relat+ to    
sub/ance use disord] m$ications to ,/ate
 prescription drug monitor+ programs1 & 
= o!r purposes4  #a4 ,%ort title ,?is   
,act may be cit$ z ! ,safe ,prescrib+   
,?r\gh ,report+ ,act ( #bjbe4  #b4      
,disclosure ( c]ta9 records relat+ to   
sub/ance use disord] m$ications to ,/ate
 prescription drug monitor+ programs    
,section #edc7;b77#b7 ( ! ,public ,heal?
 ,s]vice ,act 7#db ,u4,s4,c4            
#bij;dd-#b7;b77#b77 is am5d$ by add+ at 
! end ! foll[+3  7,e7 ,to ! applicable  
prescription drug monitor+ program ( a  
,/ate if-- 7i7 su* record relates to !  
prescrib+ or disp5s+ ( a sub/ance use   
disord] m$ication2 &  7ii7 su*          
disclosure is requir$ by applicable     

,/ate law4  4